Newborn Screening for MCAD Deficiency: Experience of the First Three Years in British Columbia, Canada

BACKGROUND: Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency is an autosomal recessive disorder of fatty acid oxidation, with potential fatal outcome. MCAD deficiency is diagnosed by acylcarnitine analysis on newborn screening blood spot cards by tandem mass spectrometry. Early diagnosis of MCA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Can J Public Health
Hlavní autoři: Horvath, Gabriella A., Davidson, A. G. F., Stockler-Ipsiroglu, Sylvia G., Lillquist, Yolanda P., Waters, Paula J., Olpin, S., Andresen, B. S., Palaty, Jan, Nelson, Judie, Vallance, Hilary
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975828/
https://ncbi.nlm.nih.gov/pubmed/18767270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/BF03403754
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky